Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Pharmacological Research
|
June 16, 2007
Protein kinase C iota: human oncogene, prognostic marker and therapeutic target
Alan P Fields, Roderick P Regala
The Journal of Continuing Education in the Health Professions
|
June 19, 2013
Improving CME: using participant satisfaction measures to specify educational methods
Jason J Olivieri, Roderick P Regala
Cancer Research
|
July 18, 2008
Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells
Roderick P Regala, E Aubrey Thompson, Alan P Fields
Cancer Research
|
September 10, 2009
Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis
Roderick P Regala, Rebecca K Davis, Alyssa Kunz, et al.
The Journal of Biological Chemistry
|
July 5, 2005
Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity
Roderick P Regala, Capella Weems, Lee Jamieson, et al.
Cancer Research
|
February 3, 2006
A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells
Melody Stallings-Mann, Lee Jamieson, Roderick P Regala, et al.
Cancer Research
|
October 6, 2005
Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer
Roderick P Regala, Capella Weems, Lee Jamieson, et al.
Plos One
|
October 25, 2011
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation
Roderick P Regala, Verline Justilien, Michael P Walsh, et al.
Plos One
|
May 1, 2012
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential
Verline Justilien, Roderick P Regala, I-Chu Tseng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Pharmacological Research
|
June 16, 2007
Protein kinase C iota: human oncogene, prognostic marker and therapeutic target
Alan P Fields, Roderick P Regala
The Journal of Continuing Education in the Health Professions
|
June 19, 2013
Improving CME: using participant satisfaction measures to specify educational methods
Jason J Olivieri, Roderick P Regala
Cancer Research
|
July 18, 2008
Atypical protein kinase C iota expression and aurothiomalate sensitivity in human lung cancer cells
Roderick P Regala, E Aubrey Thompson, Alan P Fields
Cancer Research
|
September 10, 2009
Atypical protein kinase C{iota} is required for bronchioalveolar stem cell expansion and lung tumorigenesis
Roderick P Regala, Rebecca K Davis, Alyssa Kunz, et al.
The Journal of Biological Chemistry
|
July 5, 2005
Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity
Roderick P Regala, Capella Weems, Lee Jamieson, et al.
Cancer Research
|
February 3, 2006
A novel small-molecule inhibitor of protein kinase Ciota blocks transformed growth of non-small-cell lung cancer cells
Melody Stallings-Mann, Lee Jamieson, Roderick P Regala, et al.
Cancer Research
|
October 6, 2005
Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer
Roderick P Regala, Capella Weems, Lee Jamieson, et al.
Plos One
|
October 25, 2011
Matrix metalloproteinase-10 promotes Kras-mediated bronchio-alveolar stem cell expansion and lung cancer formation
Roderick P Regala, Verline Justilien, Michael P Walsh, et al.
Plos One
|
May 1, 2012
Matrix metalloproteinase-10 is required for lung cancer stem cell maintenance, tumor initiation and metastatic potential
Verline Justilien, Roderick P Regala, I-Chu Tseng, et al.
Page
of 1